FDA Faces Criticism as Deadline to Ban Electric Shock Devices Passes

What Happened

The Food and Drug Administration has missed its deadline to finalize a ban on electrical stimulation devices (ESDs) used for behavior modification on individuals with autism and developmental disabilities. These devices deliver high-voltage, painful shocks to patients, a practice that has drawn widespread condemnation from human rights organizations.

Despite previous legislative efforts, including a 2023 law granting the agency clear authority to act, the devices remain in use. Advocacy groups, including the Citizens Commission on Human Rights, argue that the delay leaves vulnerable populations at risk of physical trauma and severe psychological harm.

Critics of the practice point to documented instances of severe injury, including burns and chronic stress. Medical professionals and global human rights entities have consistently warned that these methods are not only inhumane but counterproductive to the behavioral goals they claim to address.

The Core Points

FDA missed the legal deadline to prohibit electrical shock devices for behavioral use
Devices deliver painful, high-voltage shocks to autistic and disabled individuals
Advocacy groups are pressuring regulators to treat the practice as a human rights violation
Medical experts warn these shocks cause lasting physical and psychological damage
United Nations officials have explicitly labeled the use of these devices as torture

Context in 60 Seconds

The controversy surrounding ESDs highlights an ongoing tension between institutional psychiatric practices and evolving international human rights standards. While organizations like the United Nations and the World Health Organization increasingly classify coercive behavioral interventions as forms of structural violence, certain facilities continue to employ these measures under the umbrella of treatment.

This delay underscores the complex legal hurdles in regulating psychiatric devices, even when there is overwhelming evidence of harm. As public scrutiny grows, the debate reflects a broader societal push to end coercive practices that have historically targeted disabled individuals, forcing a re-evaluation of how mental health and behavioral care are managed in institutional settings.

Bottom Line

The FDA’s failure to enforce a ban on electric shock devices leaves vulnerable patients exposed to practices widely condemned as torture, fueling urgent calls for immediate federal action.

Loading briefing details...